KITTIKASEMSOOK, S.; TORVORAPANIT, P.; NAKARANURACK, C. Treatment outcomes and factors associated with treatment failure among patients with mild-to-moderate COVID-19 receiving five-days of oral molnupiravir vs. three-days of intravenous remdesivir in a real-world practice. Chulalongkorn Medical Journal, Bangkok, Thailand, v. 70, n. 1, 2026. Disponível em: https://he05.tci-thaijo.org/index.php/CMJ/article/view/7322. Acesso em: 16 sep. 2026.